News & Blog

Tag Archives: immunotherapy

Brain Tumor Research Highlights: July 2017

Note: In June, our 2017 Defeat GBM Research Collaborative Progress Report replaced our regular, standard monthly “Brain Tumor Research Highlights” blog. To see April’s Brain Tumor Research Highlights, click here. Over the years, NBTS has given more than $35 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing […]

From the CEO’s Desk: Glioblastoma – Grappling With A Cancer That Breaks All The Rules

A version of this op-ed first appeared this morning on the news site, STAT (statnews.com). STAT is a national publication focused on stories about health, medicine, and scientific discovery. Reports out of recent prestigious conferences and from major studies in the field, paint an optimistic picture of cancer care in America. A sampling of encouraging headlines include: […]

National Brain Tumor Society Funding and Support of Innovative Research Helps Bring About an Immunotherapy Clinical Trial With Encouraging Results

Today, encouraging results from a small, early-stage clinical trial for glioblastoma patients were reported in the scientific and medical journal, Clinical Cancer Research. The phase one study of 11 newly diagnosed glioblastoma (GBM) patients showed that combining an experimental immunotherapy with chemotherapy (temozolomide), along with an injection to prime the immune system, was well tolerated […]

Share